You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明生物(2269.HK)復牌高開9.24% 昨日被美列入UVL清單後暴跌近23%
格隆匯 02-09 09:24
格隆匯2月9日丨藥明生物今早復牌高開9.24%報68港元,市值2866億港元。該股昨日因被美納入“未經核實名單(UVL)”暴跌22.77%後上午盤中臨時停牌。藥明生物CEO陳智勝在昨日午間的媒體溝通會上表示,子公司被列入“未經核實名單”後,從美國進口的用於一次性生物反應器的控制器和中空纖維過濾器(即超濾膜包)將受到出口管制,但到底是“完全不能進口”還是“只是面臨更加嚴格的進口審批程序”,目前公司亦在進一步核實與評估中。陳智勝表示,不管是一次性生物反應器的控制器還是中空纖維過濾器,目前藥明生物均在歐美日有4、5家供應商。藥明生物昨晚也發佈公吿稱,公司正積極採取臨時措施,要求將該等子公司從未經核實名單移除。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account